EQT acquired a majority stake in London specialty broker McGill & Partners for $2 billion, buying from Warburg Pincus in a transaction that closed the same week KKR exited USI Insurance Services for a reported $17 billion. The deal marks EQT's entry into specialty reinsurance distribution and arrives eighteen months after McGill opened its doors with $400 million in Warburg backing and a roster of Lloyd's veterans.

McGill operates in reinsurance intermediation, wholesale brokerage, and specialty risk placement—segments trading at 12-16x EBITDA when backed by defensible renewal books and Lloyd's syndicate relationships. The firm's revenue reportedly exceeds $250 million annualized, implying an 8x revenue multiple at the reported valuation. Warburg's exit inside two years signals either pre-negotiated step-up provisions or margin expansion ahead of underwriting expectations. EQT inherits a platform purpose-built for acquisition velocity: McGill has completed six tuck-in acquisitions since launch, targeting teams with embedded carrier relationships and non-correlated specialty books.

The timing is not coincidental. KKR's $17 billion sale of USI to CD&R and OMERS sets the clearing price for scale brokers at a moment when margin compression in primary P&C is pushing capital toward fee-based distribution models. Specialty brokers—particularly those with Lloyd's access and reinsurance treaty desks—generate 30-40% EBITDA margins versus 18-22% for retail-heavy peers. EQT is buying margin durability and M&A infrastructure in a single check. The USI transaction, if finalized at reported valuation, will be the largest insurance services buyout in history, recalibrating what constitutes "platform scale" and implicitly raising the floor for specialty exits.

Allocators should watch three developments over the next nine to twelve months. First, whether EQT accelerates McGill's acquisition tempo with newly committed dry powder—the firm's $22 billion Infrastructure VI vehicle closed in September and its private equity flagship holds $14 billion in undeployed capital. Second, whether Warburg redeploys proceeds into another Lloyd's-adjacent build, given the firm's pattern of serial entries in fragmented services verticals. Third, the USI deal's final structure and whether CD&R finances the take-private with meaningful subscription line leverage, which would signal continued confidence in recurring-revenue insurance models despite rising rates.

The underwriting calendar does not care about acquisition timing. Treaty renewals at Lloyd's begin in Q4 2025, and McGill's platform value will be stress-tested when capacity tightens and fee compression returns.